Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Sep;22(9):2343-50.
doi: 10.1007/s00520-014-2216-1. Epub 2014 Apr 1.

Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial

Kathi H Mooney  1 , Susan L Beck, Robert H Friedman, Ramesh Farzanfar, Bob Wong
Affiliations
Randomized Controlled Trial

Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial

Kathi H Mooney et al. Support Care Cancer. 2014 Sep.

Abstract

Purpose: Monitoring patient-reported symptoms is necessary to adjust and improve supportive care during chemotherapy. Continuing advances in computerized approaches to symptom monitoring can enhance communication about unrelieved symptoms between patients and oncology providers and may facilitate intensified symptom treatment.

Methods: An automated IT-based telephone monitoring system was developed to enable oncology providers to receive and act on alert reports from patients about unrelieved symptoms during chemotherapy treatment. Daily, 250 participants (randomized to treatment or attentional control) were asked to call the automated system to report presence, severity, and distress for common chemotherapy-related symptoms (1-10 scale if present). For the treatment group, symptoms exceeding preset thresholds for moderate-to-severe intensity levels generated emailed alert reports to both the patient's oncologist and oncology nurse.

Results: Patients reported high satisfaction and ease of use of the automated system. Over 80 % of providers reported usefulness of the symptom alert reports. Ten monitored symptoms resulted in, on average, nine moderate-to-severe intensity alerts per patient over 45 study days. However, providers rarely contacted patients after receiving alerts. There were no significant differences in change of symptom severity between the two groups (mean difference = 0.06, p = 0.58).

Conclusion: Despite patients' use of a daily symptom monitoring system and providers' receipt of information about unrelieved symptoms of moderate-to-severe intensity, oncology physicians and nurses did not contact patients to intensify symptom treatment nor did symptoms improve. Further research is indicated to determine if oncology providers initiated follow-up to intensify symptom treatment, whether symptom outcomes would improve.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors have no financial relationship with the National Cancer Institute other than they had salary and benefit support during the implementation of the study.

Figures

Fig. 1
Fig. 1
CONSORT flow diagram
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Atherton P, Sloan J. Rising importance of patient-reported outcomes. Lancet Oncol. 2006;7(11):883–884. - PubMed
    1. Basch E, Abernethy A. Supporting clinical practice decisions with real-time patient-reported outcomes. J Clin Oncol. 2011;29(8):954–956. - PubMed
    1. Bren L. The importance of patient-reported outcomes. It’s all about the patients. FDA Consum. 2006;40(6):26–33. - PubMed
    1. Grenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res. 2009;18(1):115–123. - PubMed
    1. Trotti A, et al. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25(32):5121–5127. - PubMed

Publication types

Substances

LinkOut - more resources